In SKOV3 cells, combination treatments with Myc B and T-DM1 led to increased cytotoxicity compared to either agent alone, and in HER2+ tumor xenograft models, Myc B treatment suppressed both tumor growth and metastasis. Here, ERBB2 is linked to neoplasm.